SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Valentis (VLTS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SemiBull who wrote (76)7/11/2002 2:41:39 AM
From: Mike McFarland  Read Replies (1) of 81
 
Semi--do you have any opinion on all this, I bog down
when I read this stuff, in the end it is always the
same, new guys getting in ever cheaper, dilution,
repeat. Or is it more complicated than that?
Sorry to be such a simpleton.

(from form SC TO-I Tender offer statement 05/10)

"In order to obtain the funds necessary to purchase the shares of Series A Preferred Stock and related Warrants that are tendered to us, we will be offering shares of our Series B Convertible Preferred Stock, par value $0.001 per share (the "Series B Preferred Stock") in a private placement transaction. We expect the Series B Preferred Stock will have many of the same terms as the existing Series A Preferred Stock, except that the Series B Preferred Stock will be classified as equity. The new series of preferred stock will be convertible into shares of Common Stock at a fixed conversion price that is based on the current market price of the Common Stock. The shares of Series B Preferred Stock will be sold to investors pursuant to subscription agreements, such agreements to be substantially similar to the Series A Preferred Stock Subscription Agreements.

(snip)



In order to obtain the funds necessary to purchase the shares of Series A Preferred Stock and related Warrants that are tendered to us, we intend to offer shares of our Series B Preferred Stock for $1,000 per share in a private placement transaction. We expect the Series B Preferred Stock will have many of the same terms as the existing Series A Preferred Stock, except that the Series B Preferred Stock will be classified as equity. The new series of preferred stock will be convertible into shares of Common Stock at a fixed conversion price that is based on the current market price of the Common Stock. The shares of Series B Preferred Stock will be sold pursuant to subscription agreements, such agreements to be substantially similar to the Series A Preferred Stock Subscription Agreements.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext